메뉴 건너뛰기




Volumn 24, Issue 2, 1998, Pages 64-70

Making sense of nusculeskeletal disorders

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOBENZAPRINE; CYCLOPHOSPHAMIDE; GOLD DERIVATIVE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PROBENECID; SALAZOSULFAPYRIDINE; SULFINPYRAZONE; TRICYCLIC ANTIDEPRESSANT AGENT;

EID: 0031594790     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (1)

References (24)
  • 1
    • 0027209365 scopus 로고
    • Aggressive drug therapy for rheumatiod arthritis
    • McGuire JL, Ridgway WM. Aggressive drug therapy for rheumatiod arthritis. Hospital Practice. 1993;September 15: 45-52.
    • (1993) Hospital Practice , vol.15 SEPTEMBER , pp. 45-52
    • McGuire, J.L.1    Ridgway, W.M.2
  • 2
    • 0023945481 scopus 로고
    • The A.R.A. 1987 revised criteria for the classification of Rheumatiod Arthritis
    • Arnett et al. The A.R.A. 1987 revised criteria for the classification of Rheumatiod Arthritis. Arthritis Rheum. 1988;31: 315.
    • (1988) Arthritis Rheum , vol.31 , pp. 315
    • Arnett1
  • 3
    • 0027453122 scopus 로고
    • Aggressive Therapy does not substantially alter the long-term course of rheumatiod arthritis
    • Kushner I, Dawson NV. Aggressive Therapy does not substantially alter the long-term course of rheumatiod arthritis. Rheumatic Disease Clinics of North Ameria. 1993;19(1):1,
    • (1993) Rheumatic Disease Clinics of North Ameria , vol.19 , Issue.1 , pp. 1
    • Kushner, I.1    Dawson, N.V.2
  • 5
    • 2642602379 scopus 로고    scopus 로고
    • Systemic lupus erythematosus: Emerging concepts
    • AU: year
    • Boumpas DT, Austin HA, Fessier BJ. Systemic lupus erythematosus: emerging concepts. Am Int Med. [AU: year?] 122: 40-950 and 42-53.
    • Am Int Med , vol.122 , pp. 40-950
    • Boumpas, D.T.1    Austin, H.A.2    Fessier, B.J.3
  • 6
    • 12644315263 scopus 로고
    • Markedly elevated sedimentation rates: What is their clinical significant?
    • Connelly CS, Panush RS. Markedly elevated sedimentation rates: what is their clinical significant? Postgrad Adv Rheumatol. 1990;IV1-5.
    • (1990) Postgrad Adv Rheumatol
    • Connelly, C.S.1    Panush, R.S.2
  • 7
    • 0027450167 scopus 로고
    • Is "aggressive" therapy necessary for systemic lupus erythematosus?
    • Urowitz MB. Is "aggressive" therapy necessary for systemic lupus erythematosus? Rheumatic Disease Clinics of North America. 1993; 19:263-270.
    • (1993) Rheumatic Disease Clinics of North America , vol.19 , pp. 263-270
    • Urowitz, M.B.1
  • 9
    • 0026550382 scopus 로고
    • An overview of clinical spectrum and heterogeneity of spondyloarthopathies
    • Khan MA. An overview of clinical spectrum and heterogeneity of spondyloarthopathies. Rheumatic Disease Clinics of North America. 1992;18:1-10.
    • (1992) Rheumatic Disease Clinics of North America , vol.18 , pp. 1-10
    • Khan, M.A.1
  • 12
    • 0026572909 scopus 로고
    • Giant cell arteritis and polymyalgia rheumatica
    • Hunder GG. Giant cell arteritis and polymyalgia rheumatica. Hospital Practice. 1992; Jan 15:75-93.
    • (1992) Hospital Practice , vol.15 JAN , pp. 75-93
    • Hunder, G.G.1
  • 14
    • 2642596371 scopus 로고
    • Treating acute gouty arthritis
    • Ellman MH. Treating acute gouty arthritis. J. Musculoskel. Med. 1992;9(3):71-77.
    • (1992) J. Musculoskel. Med. , vol.9 , Issue.3 , pp. 71-77
    • Ellman, M.H.1
  • 15
    • 0023711661 scopus 로고
    • Clinical aspects of monosodium urate monohydrate crystal deposition disease (gout)
    • Becker MA. Clinical aspects of monosodium urate monohydrate crystal deposition disease (gout). Rheumatic Diseases of North America. 1988;14(2).
    • (1988) Rheumatic Diseases of North America , vol.14 , Issue.2
    • Becker, M.A.1
  • 16
    • 0002131430 scopus 로고
    • Calcium pyrophosphate crystal deposition disease; pseudogout; articular chondrocalcinosis
    • DJ McCarty, ed. [AU: city?] Leand Febiger
    • Ryan LM, McCarty, DJ:. Calcium pyrophosphate crystal deposition disease; pseudogout; articular chondrocalcinosis. Arthritis and Allied Conditions. DJ McCarty, ed. [AU: city?] Leand Febiger. 1989;1711-1736.
    • (1989) Arthritis and Allied Conditions , pp. 1711-1736
    • Ryan, L.M.1    McCarty, D.J.2
  • 17
  • 18
    • 0345007752 scopus 로고
    • Identifying and managing calcium pyrophosphate deposition disease
    • Terkeltaub RA. Identifying and managing calcium pyrophosphate deposition disease. J. Musculoskel. Med. 1994;11(7):29-37.
    • (1994) J. Musculoskel. Med. , vol.11 , Issue.7 , pp. 29-37
    • Terkeltaub, R.A.1
  • 19
    • 0006284267 scopus 로고
    • Measuring the functional impact of fibromyalgia
    • Silverman SI, Mason JH. Measuring the functional impact of fibromyalgia. J. Musculoskel Med. 1992;July:15-24.
    • (1992) J. Musculoskel Med. , vol.JULY , pp. 15-24
    • Silverman, S.I.1    Mason, J.H.2
  • 20
    • 1842323229 scopus 로고
    • Treatment of the fibromyalgia syndrome
    • Nies KM. Treatment of the fibromyalgia syndrome. J. Musculoskel Med. 1992;May:20-26.
    • (1992) J. Musculoskel Med. , vol.MAY , pp. 20-26
    • Nies, K.M.1
  • 21
    • 0344734609 scopus 로고
    • Clinical features and diagnosis of fibromyalgia
    • Fan PT, Blanton ME. Clinical features and diagnosis of fibromyalgia. J Musculoskel Med. 1992;April:24-42.
    • (1992) J Musculoskel Med , vol.APRIL , pp. 24-42
    • Fan, P.T.1    Blanton, M.E.2
  • 22
    • 0027165836 scopus 로고
    • Should osteoarthritis be treated with nonsteroidal anti-inflammatory drugs?
    • Brandt KD: Should osteoarthritis be treated with nonsteroidal anti-inflammatory drugs? Rheumatic Disease Clinics of North America. 1993;9(3).
    • (1993) Rheumatic Disease Clinics of North America , vol.9 , Issue.3
    • Brandt, K.D.1
  • 24
    • 2642688957 scopus 로고
    • Assessing the patient with osteoarthritis: A regional approach
    • Bluestone R. Assessing the patient with osteoarthritis: a regional approach. J Musculoskel Med. 1993;December:46-54.
    • (1993) J Musculoskel Med , vol.DECEMBER , pp. 46-54
    • Bluestone, R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.